“The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study.”, Ophthalmology, vol. 110, no. 9, pp. 1683-9, 2003.
, “National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10.”, Arch Ophthalmol, vol. 121, no. 2, pp. 211-7, 2003.
, “Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27.”, Diabetes Care, vol. 28, no. 3, pp. 617-25, 2005.
, “Complement factor H polymorphism in age-related macular degeneration.”, Science, vol. 308, no. 5720, pp. 385-9, 2005.
, “A simplified severity scale for age-related macular degeneration: AREDS Report No. 18.”, Arch Ophthalmol, vol. 123, no. 11, pp. 1570-4, 2005.
, “Dose-ranging study of lutein supplementation in persons aged 60 years or older.”, Invest Ophthalmol Vis Sci, vol. 47, no. 12, pp. 5227-33, 2006.
, “The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older.”, Invest Ophthalmol Vis Sci, vol. 47, no. 12, pp. 5234-42, 2006.
, “Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.”, Retina, vol. 27, no. 2, pp. 150-8, 2007.
, “The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.”, Arch Ophthalmol, vol. 125, no. 9, pp. 1225-32, 2007.
, “The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20.”, Arch Ophthalmol, vol. 125, no. 5, pp. 671-9, 2007.
, “Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis.”, Circulation, vol. 117, no. 16, pp. 2104-13, 2008.
, “Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease.”, Ophthalmology, vol. 115, no. 11, pp. 1957-64, 2008.
, “The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.”, Invest Ophthalmol Vis Sci, vol. 49, no. 10, pp. 4340-6, 2008.
, “Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.”, Invest Ophthalmol Vis Sci, vol. 49, no. 9, pp. 3864-9, 2008.
, “The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23.”, Arch Ophthalmol, vol. 126, no. 9, pp. 1274-9, 2008.
, “Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration.”, PLoS One, vol. 4, no. 5, p. e5508, 2009.
, “{omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study.”, Am J Clin Nutr, vol. 90, no. 6, pp. 1601-7, 2009.
, “Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration.”, Arch Ophthalmol, vol. 127, no. 1, pp. 110-2, 2009.
, “Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25.”, Ophthalmology, vol. 116, no. 2, pp. 297-303, 2009.
, “Summary results and recommendations from the age-related eye disease study.”, Arch Ophthalmol, vol. 127, no. 12, pp. 1678-9, 2009.
, “Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: age-related eye disease study report no. 27.”, Ophthalmology, vol. 116, no. 11, pp. 2093-100, 2009.
, “Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2.”, Ophthalmic Epidemiol, vol. 17, no. 1, pp. 66-73, 2010.
, “Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31.”, Ophthalmology, vol. 117, no. 11, pp. 2112-9.e3, 2010.
, “Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28.”, Ophthalmology, vol. 117, no. 3, pp. 489-99, 2010.
, “Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema.”, Retina, vol. 30, no. 3, pp. 459-67, 2010.
,